
A Kaiser score > 5 with breast MRI demonstrated a 97 percent sensitivity and 87.9 percent specificity for predicting malignancy in patients with BI-RADS 0 or 4 presentations on mammography and breast ultrasound, according to a new study.
The FDA has approved the use of CADX Systems' Second Look Digital computer-aided detection system as an integral part of Fischer Imaging's SenoScan TrueView full-field digital mammography system. The agency had approved the two systems previously for
The FDA has approved the use of CADX Systems' Second Look Digital computer-aided detection system as an integral part of Fischer Imaging's SenoScan TrueView full-field digital mammography system. The agency had approved the two systems previously for sale as stand-alone products.



